Spectrum Business Receives Frost & Sullivan’s 2025 North American Competitive Strategy Leadership Recognition for Excellence in Dedicated Internet Access
Spectrum Business Leverages Digital Innovation and Customer-Centric Execution to Drive Strategic Excellence…
NTG Nordic Transport Group publishes interim report for Q3 2025
Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport…
Saudi Emerge Emergency and Crisis Resilience Platform Named Among the Worlds Best Smart City Solutions in the 2025 Smart City Awards
A national innovation supporting future-ready cities and major global event readiness…through a…
Lamborghini World Finals 2025: Danny Formal and Hampus Ericsson crowned Pro champions at Misano Adriatico
Orudzhev-Abkhazava (Pro-Am), Ciglia-Perolini (Am) and Ojjeh (Lamborghini Cup) secure other class titles…
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume…
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025
London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage…
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
November 09, 2025 09:00 ET | Source: Medera Inc. BOSTON, Nov. 09,…
Biban Forum 2025 Concludes in Riyadh with Agreements Worth Over USD 10.1 Billion and Record Global Participation
RIYADH, Saudi Arabia, Nov. 9, 2025 /PRNewswire/ -- The Small and Medium…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…
NEXEN TIRE Achieves KRW 780.7 Billion in Sales, 10% YoY Growth in Q3 2025
Sales growth driven by launching region-specific products, expanding the distribution network, and…
